These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10411013)

  • 1. Efficacy of calcium supplements on bone mass in postmenopausal women.
    Chiu KM
    J Gerontol A Biol Sci Med Sci; 1999 Jun; 54(6):M275-80. PubMed ID: 10411013
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-collagen chelate supplementation reduces bone loss in osteopenic postmenopausal women.
    Castelo-Branco C
    Climacteric; 2015 Feb; 18(1):105-6. PubMed ID: 25734209
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Wu J; Xu L; Lv Y; Dong L; Zheng Q; Li L
    Osteoporos Int; 2017 Jun; 28(6):2003-2010. PubMed ID: 28337524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium in the prevention and treatment of osteoporosis].
    Burckhardt P
    Ther Umsch; 1991 Feb; 48(2):107-12. PubMed ID: 2035165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium supplementation and bone loss: a review of controlled clinical trials.
    Dawson-Hughes B
    Am J Clin Nutr; 1991 Jul; 54(1 Suppl):274S-280S. PubMed ID: 2053573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
    Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
    J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Inquiries: Does vitamin D without calcium reduce fracture risk?
    Daly S; Allison C; Nashelsky J
    J Fam Pract; 2016 Dec; 65(12):933-934. PubMed ID: 28149982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between bone mass density and osteoporosis risk factors in postmenopausal women].
    Bulgakova SV; Davydkin IL
    Ter Arkh; 2009; 81(1):76-9. PubMed ID: 19253718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium therapy in women following menopause].
    Dtsch Med Wochenschr; 1993 Nov; 118(45):1667. PubMed ID: 8223232
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation.
    Chailurkit LO; Saetung S; Thakkinstian A; Ongphiphadhanakul B; Rajatanavin R
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):167-72. PubMed ID: 20148911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation and bone mineral density in early postmenopausal women.
    Cooper L; Clifton-Bligh PB; Nery ML; Figtree G; Twigg S; Hibbert E; Robinson BG
    Am J Clin Nutr; 2003 May; 77(5):1324-9. PubMed ID: 12716689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
    Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
    Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.
    Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
    Am J Med; 1995 Apr; 98(4):331-5. PubMed ID: 7709944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis: protecting bone mass with fundamentals and drug therapy.
    Kleerekoper M
    Geriatrics; 1999 Jul; 54(7):38-43; quiz 44. PubMed ID: 10431598
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
    Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3817-25. PubMed ID: 9814452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and vitamin D in promotion of postmenopausal bone health.
    Honkanen R; Kärkkäinen M; Kröger H
    Womens Health (Lond); 2010 Nov; 6(6):773-6. PubMed ID: 21118034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.